Stanhope and Cadillac Fairview sign new biopharma tenant at White City Place
Biopharmaceutical company invoX Pharma has established its new headquarters in the WestWorks building at White City Place, W12.
The move follows the company’s opening of a centre of excellence in antibody research and clinical development in Cambridge.
InvoX, a subsidiary of Sino Biopharmaceutical, will occupy 2,500 sq ft of workspace in the building, which has rents ranging from £50 to £60 per sq ft.
Biopharmaceutical company invoX Pharma has established its new headquarters in the WestWorks building at White City Place, W12.
The move follows the company’s opening of a centre of excellence in antibody research and clinical development in Cambridge.
InvoX, a subsidiary of Sino Biopharmaceutical, will occupy 2,500 sq ft of workspace in the building, which has rents ranging from £50 to £60 per sq ft.
The site, brought forward by Stanhope and Cadillac Fairview, forms part of the White City innovation district, being developed with Imperial College London.
White City Place is already home to Novartis, Autolus, Takeda, Engitix, Synthace and Vivan Therapeutics, totalling more than 130,000 sq ft. The scheme is also the chosen location for London’s first “BioHotel”.
David Camp, chief executive of Stanhope, said: “White City Place has rapidly become a leading life sciences hub and, as part of the White City Innovation District, is competing on the global stage at the cutting edge of sustainable development.”
Stanhope and its partners Mitsui Fudosan and AIMCo are continuing to develop White City Place by bringing forward the Gateway scheme.
To send feedback, e-mail evelina.grecenko@eg.co.uk or tweet @Gre_Eve or @EGPropertyNews
See which agents are doing the most deals in the London submarkets with our On-Demand Rankings >>
Photo courtesy of Jefferson Communications
